Application no. and date | 17209680.2 (espacenet) (Federated) (European Patent Register), 20121116 | Patent/reg. no. and date | DK/EP 3366775, 20220427 | Publication date | 20180829 | Priority no. and date | US 201161561710 P, 20111118 | EP pub. no. and date |
EP 3366775 20180829 | Effective date | | Applicant/owner | Alnylam Pharmaceuticals, Inc., 300 Third Street
Cambridge, MA 02142, US | Applicant ref. no. | 1640984 | Inventor | Manoharan, Muthiah, c/o Alnylam Pharmaceuticals, Inc. 300 Third Street
Cambridge, MA 02142, US, Rajeev, Kallanthottathil, G., c/o Alnylam Pharmaceuticals, INC. 300 Third Street
Cambridge, MA 02142, US, Maier, Martin, c/o Alnylam Pharmaceuticals, INC. 300 Third Street
Cambridge, MA 02142, US, ZIMMERMANN, Tracy, c/o Alnylam Pharmaceuticals, Inc. 300 Third Street
Cambridge, MA 02142, US, KUCHIMANCHI, Satyanarayana, c/o Alnylam Pharmaceuticals, Inc. 300 Third Street
Cambridge, MA 02142, US, CHARISSE, Klaus, c/o Alnylam Pharmaceuticals, Inc. 300 Third Street
Cambridge, MA 02142, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/7125 (2006.01) , C12N 15/113 (2010.01) | Title | MODIFICEREDE RNAI-MIDLER | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|